XML 31 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Unaudited Interim Consolidated Statement Equity - USD ($)
Total
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Noncontrolling Interest [Member]
Balance as of the beginning of the period, shares at Dec. 31, 2017   135,769,256 32,387,713        
Total Celanese Corporation stockholders' equity at Dec. 31, 2017   $ 0 $ (2,031,000,000) $ 175,000,000 $ 4,920,000,000 $ (177,000,000)  
Stock option exercises, shares   0          
Stock option exercises   $ 0   0      
Purchases of treasury stock, shares   0          
Purchases of treasury stock   $ 0          
Stock awards, shares   86,454          
Stock awards   $ 0          
Purchases of treasury stock, shares 0   0        
Purchases of treasury stock, including related fees $ 0   $ 0        
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures     0        
Stock-based compensation, net of tax     $ 0 17,000,000      
Net earnings (loss) attributable to Celanese Corporation 363,000,000       363,000,000    
Common stock dividends         63,000,000    
Other comprehensive income (loss), net of tax 49,000,000         49,000,000  
Balance as of the end of the period, shares at Mar. 31, 2018   135,855,710 32,387,713        
Stockholders' Equity Attributable to Noncontrolling Interest at Dec. 31, 2017             $ 412,000,000
Net earnings (loss) attributable to noncontrolling interests 2,000,000           2,000,000
(Distributions to) contributions from noncontrolling interests             2,000,000
Stockholders' Equity Attributable to Noncontrolling Interest at Mar. 31, 2018             412,000,000
Total Celanese Corporation stockholders' equity at Mar. 31, 2018 3,253,000,000 $ 0 $ (2,031,000,000) 192,000,000 5,220,000,000 (128,000,000)  
Balance as of the end of the period at Mar. 31, 2018 3,665,000,000            
Balance as of the beginning of the period, shares at Dec. 31, 2018   128,095,849 40,323,105        
Balance as of the beginning of the period at Dec. 31, 2018 3,379,000,000            
Total Celanese Corporation stockholders' equity at Dec. 31, 2018 $ 2,984,000,000 $ 0 $ (2,849,000,000) 233,000,000 5,847,000,000 (247,000,000)  
Stock option exercises, shares   9,937          
Stock option exercises   $ 0   (1,000,000)      
Purchases of treasury stock, shares   (1,972,291)          
Purchases of treasury stock   $ 0          
Stock awards, shares   478,997          
Stock awards   $ 0          
Purchases of treasury stock, shares 1,972,291   1,972,291        
Purchases of treasury stock, including related fees $ (200,000,000)   $ 200,000,000        
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures     (9,937)        
Stock-based compensation, net of tax     $ 1,000,000 (8,000,000)      
Net earnings (loss) attributable to Celanese Corporation 337,000,000       337,000,000    
Common stock dividends         70,000,000    
Other comprehensive income (loss), net of tax 4,000,000         4,000,000  
Balance as of the end of the period, shares at Mar. 31, 2019   126,612,492 42,285,459        
Stockholders' Equity Attributable to Noncontrolling Interest at Dec. 31, 2018 395,000,000           395,000,000
Net earnings (loss) attributable to noncontrolling interests 1,000,000           1,000,000
(Distributions to) contributions from noncontrolling interests             4,000,000
Stockholders' Equity Attributable to Noncontrolling Interest at Mar. 31, 2019 392,000,000           $ 392,000,000
Total Celanese Corporation stockholders' equity at Mar. 31, 2019 3,047,000,000 $ 0 $ (3,048,000,000) $ 224,000,000 $ 6,114,000,000 $ (243,000,000)  
Balance as of the end of the period at Mar. 31, 2019 $ 3,439,000,000